DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non‐malignant phenotype

International Journal of Cancer

Volumn 52, Issue 6, 1992, Pages 896-902

  Chang, Sidney E ^a   Foster, Sharon ^a   Betts, David ^b   Marnock, Wendy E ^a  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; DYSPLASIA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH MUCOSA; ONCOGENE; PRIORITY JOURNAL; SMOKING; TONGUE;

ANIMAL; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMAN; KARYOTYPING; KERATINOCYTES; MALE; MICE; MICE, NUDE; MIDDLE AGE; MOUTH MUCOSA; MOUTH NEOPLASMS; PHENOTYPE; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0026683812     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910520612     Document Type: Article

References (30)

1. Growth and characterisation of human attached gingival, sulcular and junctional epitheliain vitro
2. Isolation of human‐P53‐Specific monoclonal antibodies and their use in the studies of human p53 expression
3. Human oral keratinocyte cultures and in vitro model systems for studying oral carcinogenesis
4. Ras mutations in United Kingdom examples of oral malignancies are infrequent
5. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papilloma virus type 16 DNA
6. Cyclic AMP in relation to proliferation of the epidermal cell: a new view
7. Expression of p53 in pre‐Malignant and malignant squamous epithelium
8. Monoclonal antibodies specific for simian virus 40 tumour antigens
9. Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organisation
10. Keratin antigens in differentiating skin
11. Supra‐Basal 40 kd keratin (k19) expression as an immunohistologic marker of pre‐Malignancy in oral epithelium
12. Human papilloma virus type 16 alters human epithelial‐Cell differentiationin vitro
13. Events of tumour progression associated with carcinogen treatment of epithelial and fibroblast compared with mutagenic events
14. Comparative stages of expression of human squamous carcinoma cells and carcinogen‐Transformed keratinocytes
15. Potential applications of anti‐Keratin antibodies in oral diagnosis
16. Cytoplasmic markers of disturbed epithelial differentiation as markers of high‐Risk lesions with special reference to cytokeratins
17. Assessment of p53 protein expression in normal, benign and malignant oral mucosa
18. Antibody markers of basal cells in complex epithelia
19. Low incidence of ras oncogene activity in human squamous cell carcinomas
20. Most human squamous‐Cell carcinomas in the oral cavity contain mutated p53 tumor‐Suppressor genes
21. High‐Frequency mutation in codons 12 and 61 of H‐Ras oncogene in chewing‐Tobacco‐Related human oral carcinoma in India
22. Changing patterns of keratin expression during progression of cervical intra‐Epithelial neoplasia
23. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene
24. Keratin 19:predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins
25. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c‐H‐Ras‐I and concurrent amplification of c‐ErbB‐1 and c‐Myc
26. Cell‐Type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins numbers 4 and 13
27. Differentiation‐Related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn and adult epidermis
28. Mutations activating human c‐Ha‐Ras1 proto‐Oncogene (hRAS1) induced by chemical carcinogens and depurination
29. Point mutations in the Ha‐Ras oncogene are detectable in formalin‐Fixed tissues of oral squamous‐Cell carcinomas, but are infrequent in British patients